Language

News topic

Expected end: 2026-05

All current shortage notices related to Expected end: 2026-05, structured by product, country, active ingredient and reporting period.

12 notices

← All shortages

Belgium

Sevikar-HCT 40 mg - 5 mg - 12.5 mg filmomh. tabl. 28

Active ingredient: Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide

View notice details →
Belgium

Sevikar-HCT 40 mg - 10 mg - 12.5 mg filmomh. tabl. 98

Active ingredient: Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide

View notice details →
Belgium

Metformine Viatris 850 mg filmomh. tabl. 100

Active ingredient: Metformin

View notice details →
Belgium

Venlafaxin Retard Sandoz 75 mg harde caps. verl. afgifte 98

Active ingredient: Venlafaxine

View notice details →
Belgium

Vardenafil Krka 20 mg filmomh. tabl. 12 (12 x 1) UD

Active ingredient: Vardenafil

View notice details →
Belgium

Risperidon Sandoz 1 mg filmomh. tabl. 60

Active ingredient: Risperidone

View notice details →
Belgium

Levocetirizine Sandoz 5 mg filmomh. tabl. 20

Active ingredient: Levocetirizine

View notice details →
Belgium

Vizarsin 100 mg orodisp. tabl. 24 (24 x 1) UD

Active ingredient: Sildenafil

View notice details →
Belgium

Sevikar-HCT 20 mg - 5 mg - 12.5 mg filmomh. tabl. 28

Active ingredient: Olmesartan Medoxomil; Amlodipine; Hydrochlorothiazide

View notice details →
Belgium

Gynoxin 2 % vagin. crème 35 g

Active ingredient: Fenticonazole Nitrate

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.